PT2040703E - Derivados de 2-benzoil-imidazopiridinas, sua preparação e sua aplicação em terapia - Google Patents

Derivados de 2-benzoil-imidazopiridinas, sua preparação e sua aplicação em terapia Download PDF

Info

Publication number
PT2040703E
PT2040703E PT07803831T PT07803831T PT2040703E PT 2040703 E PT2040703 E PT 2040703E PT 07803831 T PT07803831 T PT 07803831T PT 07803831 T PT07803831 T PT 07803831T PT 2040703 E PT2040703 E PT 2040703E
Authority
PT
Portugal
Prior art keywords
preparation
imidazopyridines
therapeutics
benzoyl
derivatives
Prior art date
Application number
PT07803831T
Other languages
English (en)
Inventor
Youssef El-Ahmad
Jean-Francois Peyronel
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of PT2040703E publication Critical patent/PT2040703E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
PT07803831T 2006-07-03 2007-07-03 Derivados de 2-benzoil-imidazopiridinas, sua preparação e sua aplicação em terapia PT2040703E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0606010A FR2903105A1 (fr) 2006-07-03 2006-07-03 Derives de 2-benzoyl-imidazopyridines, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
PT2040703E true PT2040703E (pt) 2010-01-19

Family

ID=37661856

Family Applications (1)

Application Number Title Priority Date Filing Date
PT07803831T PT2040703E (pt) 2006-07-03 2007-07-03 Derivados de 2-benzoil-imidazopiridinas, sua preparação e sua aplicação em terapia

Country Status (21)

Country Link
US (1) US7902219B2 (pt)
EP (1) EP2040703B1 (pt)
JP (1) JP2009541469A (pt)
KR (1) KR20090024775A (pt)
CN (1) CN101484163A (pt)
AT (1) ATE446089T1 (pt)
AU (1) AU2007271082A1 (pt)
BR (1) BRPI0713260A2 (pt)
CA (1) CA2656045A1 (pt)
CY (1) CY1109743T1 (pt)
DE (1) DE602007002915D1 (pt)
DK (1) DK2040703T3 (pt)
ES (1) ES2335323T3 (pt)
FR (1) FR2903105A1 (pt)
IL (1) IL195818A0 (pt)
MX (1) MX2008016558A (pt)
PL (1) PL2040703T3 (pt)
PT (1) PT2040703E (pt)
RU (1) RU2009103300A (pt)
SI (1) SI2040703T1 (pt)
WO (1) WO2008003854A2 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2925907B1 (fr) * 2008-01-02 2010-10-15 Sanofi Aventis DERIVES DE 2-HETEROAROYL-IMIDAZO°1,2-a!PYRIDINE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
FR2925905B1 (fr) * 2008-01-02 2010-11-05 Sanofi Aventis DERIVES DE 2-BENZOYL-IMIDAZO°1,2-a!PYRIDINE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
FR2928924B1 (fr) * 2008-03-21 2010-04-23 Sanofi Aventis Derives polysubstitues de 6-heteroaryle-imidazo°1,2-a! pyridines, leur preparation et leur application en therapeutique
FR2928921B1 (fr) * 2008-03-21 2010-04-23 Sanofi Aventis Derives polysubstitues de 2-aryl-6-phenyl-imidazo°1,2-a!pyridines, leur preparation et leur application en therapeutique
FR2928922B1 (fr) * 2008-03-21 2010-04-23 Sanofi Aventis Derives de 2-aryl-6-phenyl-imidazo°1,2-a!pyridines polysubstitues, leur preparation et leur application en therapeutique
FR2928923B1 (fr) * 2008-03-21 2010-04-23 Sanofi Aventis Derives polysubstitues de 2-heteroaryl-6-phenyl-imidazo °1,2-a!pyridines, leur preparation et leur application en therapeutiques
FR2933609B1 (fr) 2008-07-10 2010-08-27 Fournier Lab Sa Utilisation de derives d'indole comme activateurs de nurr-1, pour le traitement de la maladie de parkinson.
FR2950053B1 (fr) 2009-09-11 2014-08-01 Fournier Lab Sa Utilisation de derives d'indole benzoique comme activateurs de nurr-1, pour le traitement de la maladie de parkinson
FR2955110A1 (fr) 2010-01-08 2011-07-15 Fournier Lab Sa Nouveaux derives de type pyrrolopyridine benzoique
CN103772381B (zh) * 2013-09-16 2015-11-25 广东华南新药创制中心 一种四稠环喹啉类化合物及其制备方法
WO2021204626A1 (en) 2020-04-06 2021-10-14 Almirall, S.A. Aryl and heteroaryl-carboxamide substituted heteroaryl compounds as tyk2 inhibitors

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2638161B1 (fr) * 1988-10-24 1991-01-11 Centre Nat Rech Scient Nouvelles benzoyl-2 imidazo (1,2-a) pyridines et leurs sels, leur procede de preparation, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant
AU2001249672A1 (en) * 2000-03-31 2001-10-15 Ortho-Mcneil Pharmaceutical, Inc. Method for using 2- or 3-aryl substituted imidazo(1,2-a) pyridines as h3 antagonists
DE10117184A1 (de) 2001-04-05 2002-10-17 Gruenenthal Gmbh Substituierte Imidazol[1,2-a]-pyridin-3-yl-amid- und -aminverbindungen
EP1465869B1 (en) * 2001-12-21 2013-05-15 Exelixis Patent Company LLC Modulators of lxr
GB0303503D0 (en) 2003-02-14 2003-03-19 Novartis Ag Organic compounds
JP2006522794A (ja) * 2003-04-10 2006-10-05 ファイザー株式会社 Ｎｒ２ｂ受容体拮抗物質としての二環系化合物
PE20050952A1 (es) 2003-09-24 2005-12-19 Novartis Ag Derivados de isoquinolina como inhibidores de b-raf
EP1677791A4 (en) * 2003-10-31 2007-08-15 Takeda Pharmaceutical NITROGENIC CONDENSED HETEROCYCLIC COMPOUNDS
US7750160B2 (en) 2003-11-13 2010-07-06 Ambit Biosciences Corporation Isoxazolyl urea derivatives as kinase modulators
CN101048388A (zh) 2004-08-31 2007-10-03 阿斯利康(瑞典)有限公司 喹唑啉酮衍生物及其作为B－Raf抑制剂的用途
CA2589773A1 (en) 2004-12-22 2006-06-29 Astrazeneca Ab Pyridine carboxamide derivatives for use as anticancer agents
WO2006067445A2 (en) 2004-12-22 2006-06-29 Astrazeneca Ab Csf-1r kinase inhibitors

Also Published As

Publication number Publication date
DK2040703T3 (da) 2010-03-08
MX2008016558A (es) 2009-05-20
CA2656045A1 (fr) 2008-01-10
JP2009541469A (ja) 2009-11-26
ES2335323T3 (es) 2010-03-24
PL2040703T3 (pl) 2010-03-31
EP2040703B1 (fr) 2009-10-21
FR2903105A1 (fr) 2008-01-04
ATE446089T1 (de) 2009-11-15
DE602007002915D1 (de) 2009-12-03
CN101484163A (zh) 2009-07-15
AU2007271082A1 (en) 2008-01-10
WO2008003854A3 (fr) 2008-03-06
KR20090024775A (ko) 2009-03-09
WO2008003854A2 (fr) 2008-01-10
EP2040703A2 (fr) 2009-04-01
CY1109743T1 (el) 2014-09-10
US7902219B2 (en) 2011-03-08
US20090143420A1 (en) 2009-06-04
SI2040703T1 (sl) 2010-02-26
RU2009103300A (ru) 2010-08-10
BRPI0713260A2 (pt) 2012-04-03
IL195818A0 (en) 2009-09-01

Similar Documents

Publication Publication Date Title
IL195818A0 (en) Derivatives of 2-benzoyl-imidazopyridines, preparation ,method thereof and use of same in therapeutics
SI2041133T1 (sl) Imidazo (1,2,a)piridin-2-karboksamidni derivati, njihova priprava in njihova uporaba v terapevtiki
TW200606162A (en) Pyrazolopyridine derivatives
WO2009066152A3 (en) Haloallylamine inhibitors of ssao/vap-1 and uses therefor
UA89968C2 (uk) Похідні піроло[3,2-d]-піримідин-4-ону та їх застосування у терапії
GEP20084551B (en) 4-phenylamino-quinazolin-6-yl-amides
WO2007131072A3 (en) Hydrolytically-resistant boron-containing therapeutics and methods of use
PH12013502100A1 (en) Salts and crystal forms of 2-methyl-2-[4-(3-methyl-2-oxo-8-quinolin -3-yl-2,3-dyhydroimidazo[4,5-c]quinolin-1-yl)-phenyl]-propionitrile
PL1730147T3 (pl) Podstawowe związki 1,4,8-triazaspiro[4.5]dekan-2-onu
TW200740773A (en) Diaminopyrimidines as P2X3 and P2X2/3 modulators
TW200806299A (en) Treatment of pain
WO2009026176A3 (en) Antiinfective flavononol compounds and methods of use thereof
TW200639159A (en) Treatment of pain
HK1138262A1 (en) Novel phosphodiesterase inhibitors
SI1730144T1 (sl) Substituirane spojine 1,4,8-triazaspiro(4.5)dekan-2-on
MX2009010165A (es) Nuevas imidazo[4,5-b]piridina-7-carboxamidas 704.
MY150747A (en) Pyrido[2,3-d] pyrimidin-7-one compounds as inhibitors of pi3k-alpha for the treatment of cancer
MX2010009756A (es) Agonistas de receptores muscarinicos, composiciones, metodos de tratamiento de los mismos, y proceso para preparacion de los mismos.
TNSN08506A1 (en) Substituted carboxamides
TW200626581A (en) Compounds, compositions containing them, preparation thereof and uses thereof
MX2009006325A (es) Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales.
MX2009005912A (es) Derivados de etilamina-fenilo heterociclilo sustituidos, su preparacion y uso como medicamentos.
UA98639C2 (en) Phosphodiesterase inhibitors
WO2009069764A1 (ja) オピオイド鎮痛剤
MX2008013477A (es) Compuestos biciclicos de tetrahidropirrol.